Artiva Biotherapeutics, Inc.(ARTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ARTV Artiva Biotherapeutics, Inc.

Closed Mourning Day 01-08 16:00:00 EST

10.26

-0.32

-3.02%

盘后10.26

+0.000.00%

16:01 EST

High11.55	Low10.00	Vol62.38K
Open10.00	D1 Closing10.58	Amplitude14.65%
Mkt Cap249.21M	Tradable Cap44.35M	Total Shares24.29M
T/O667.52K	T/O Rate1.44%	Tradable Shares4.32M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":10.26,"timestamp":1736370000000,"preClose":10.58,"halted":0,"volume":62378,"hourTrading":{"tag":"盘后","latestPrice":10.26,"preClose":10.26,"latestTime":"16:01 EST","volume":623,"amount":6391.98,"timestamp":1736370070970},"delay":0,"floatShares":4323072,"shares":24289328,"eps":-11.422745,"marketStatus":"Closed Mourning Day","change":-0.32,"latestTime":"01-08 16:00:00 EST","open":10.0001,"high":11.55,"low":10.0001,"amount":667523.4487,"amplitude":0.146493,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.422745,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1736499600000},"marketStatusCode":7,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":10.58,"preHourTrading":{"tag":"盘前","latestPrice":10.31,"preClose":10.58,"latestTime":"08:30 EST","volume":2,"amount":20.62,"timestamp":1736343025044},"postHourTrading":{"tag":"盘后","latestPrice":10.26,"preClose":10.26,"latestTime":"16:01 EST","volume":623,"amount":6391.98,"timestamp":1736370070970},"volumeRatio":1.2026946805241925},"requestUrl":"/m/hq/s/ARTV/tweets","defaultTab":"tweets","newsList":[{"id":"2495492579","title":"BUZZ-U.S. STOCKS ON THE MOVE-Vivid Seats, Cheniere Energy, U.S. natural gas producers","url":"https://stock-news.laohu8.com/highlight/detail?id=2495492579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495492579?lang=en_us&edition=fundamental","pubTime":"2024-12-31 02:35","pubTimestamp":1735583717,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Vivid Seats, Cheniere Energy, U.S. natural gas producersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NV0NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B29SXK94.USD","INGN","BKV","BK4007","BK4122","LU0368265418.SGD","BK4559","LU1169589451.USD","SEAT","BK4532","LU0251131958.USD","LU0006061336.USD","LU1043141396.HKD","LU2449327464.USD","LU1435385759.SGD","LU0788109394.HKD","BA","VRSN","IE00B7SZLL34.SGD","BK4547","LU1169590202.USD","LU2506951958.HKD","ARTV","LU0823417653.USD","LU1571399168.USD","IE0002270589.USD","LU0048573561.USD","BK4564","SDA","BK4588","LU0426417589.USD","LU1043141123.HKD","EXE","AXSM","SG9999001440.SGD","EQT","LU0314104364.USD","LU0234570918.USD","BK4551","LU0170899867.USD","BK4116","LNG","LU0994945656.USD","CTRA","AAL","BK4213","LU0348723411.USD","BK4505","BK4139","LU0122376428.USD"],"gpt_icon":1},{"id":"2495540030","title":"BUZZ-U.S. STOCKS ON THE MOVE-Inogen, VeriSign, Boeing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495540030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495540030?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:18","pubTimestamp":1735568310,"startTime":"0","endTime":"0","summary":"Dec 30 (Reuters) -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NV0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951875.HKD","VRSN","LU0348723411.USD","LU1043141123.HKD","BK4547","LU0426412945.USD","LU0426417589.USD","BK4559","LU1435385759.SGD","LU2326559502.SGD","LU2506951958.HKD","LU0950375773.USD","LU2506952097.USD","INGN","BK4516","BK4007","LU1043141396.HKD","LU1121112475.USD","BK4564","LU0234570918.USD","AAL","BK4532","AXSM","BA","BK4008","BK4505","BK4139","LU1429558221.USD","BK4585","BK4187","LU0823417737.USD","LU0823417653.USD","ARTV","BK4082","BK4500","BK4116","LU2506952170.USD","LU0994945656.USD","BK4588","LU1571399168.USD","BK4551"],"gpt_icon":1},{"id":"2495544469","title":"BUZZ-U.S. STOCKS ON THE MOVE-Artiva Biotherapeutics, Axsome Therapeutics, American Airlines","url":"https://stock-news.laohu8.com/highlight/detail?id=2495544469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495544469?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:18","pubTimestamp":1735564715,"startTime":"0","endTime":"0","summary":"Dec 30 (Reuters) -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NV0HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4008","BK4139","BK4588","BK4500","BK4547","BK4585","BK4007","AXSM","ARTV","BK4505","AAL"],"gpt_icon":0},{"id":"2495810546","title":"HC Wainwright Initiates Artiva Biotherapeutics at Buy With $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2495810546","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495810546?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:22","pubTimestamp":1735561323,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (ARTV) has an average rating of buy and mean price target of $21, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTV"],"gpt_icon":0},{"id":"2495545527","title":"BUZZ-H.C. Wainwright starts coverage of Artiva Biotherapeutics with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2495545527","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495545527?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:09","pubTimestamp":1735560565,"startTime":"0","endTime":"0","summary":"BUZZ-H.C. Wainwright starts coverage of Artiva Biotherapeutics with 'buy' rating** Brokerage H.C. Wainwright starts coverage of drug developer Artiva Biotherapeutics ARTV.O with \"buy\" rating and PT of $20** PT represents an ~88% upside to stock's last close** Co is testing its experimental drug, AlloNK, for an autoimmune disease called systemic lupus erythematosus  in combination with antibodies Rituxan or Gazyva** SLE is a condition where the immune system attacks the body's own tissues ** Brokerage notes \"current treatment options do not effectively control disease progression\"** Says AlloNK costs less than $6,000 per patient for ARTV to produce, compared to ~$100,000 for auto-CAR T therapies ** Co has capacity to produce enough AlloNK for over 1,000 autoimmune patients annually, H.C. Wainwright says** Brokerage expects AlloNK to launch by 2029 and forecasts sales to grow to $531 mln by 2031** As of last close, stock has fallen ~34% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NV0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2495543120","title":"Artiva Biotherapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2495543120","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495543120?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:55","pubTimestamp":1735559700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2024 06:55 ET (11:55 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2495354814","title":"U.S. RESEARCH ROUNDUP- Arcutis Biotherapeutics, Artiva Biotherapeutics, Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2495354814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495354814?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:40","pubTimestamp":1735558819,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Arcutis Biotherapeutics, Artiva Biotherapeutics, Nuvalent Dec 30  - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arcutis Biotherapeutics, Artiva Biotherapeutics and Nuvalent on Monday.  HIGHLIGHTS    * Arcutis Biotherapeutics ARQT.O: H.C. Wainwright initiates coverage with buy rating* Artiva Biotherapeutics ARTV.O: H.C. Wainwright initiates coverage with buy rating * Nuvalent Inc NUVL.O: H.C. Wainwright initiates coverage with buy rating and PT $110Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order* Arcutis Biotherapeutics ARQT.O: H.C. Wainwright initiates coverage with buy rating* Artiva Biotherapeutics ARTV.O: H.C. Wainwright initiates coverage with buy rating * BigBear.ai Holdings Inc BBAI.N: H.C. Wainwright raises PT to $7 from $3* Boston Scientific Corp BSX.N: BTIG raises target price to $101 from $97 * Emerg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NV0FC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491050154.USD","LU0187121727.USD","IE00B4R5TH58.HKD","LU0011850046.USD","LU0238689110.USD","NUVL","EXEL","LU0823417737.USD","LU2491050071.SGD","BSX","LU1718418525.SGD","LU1023059063.AUD","LU2324357040.USD","MTVA","LU1791710582.SGD","LU2506952097.USD","BK4139","BK4551","IE0002141913.USD","LU0353189680.USD","LU0122379950.USD","LU2265009873.SGD","LU0048584097.USD","LU0267386448.USD","LU1989772923.USD","PODD","ARTV","LU0345769128.USD","LU0823416689.USD","LU1153585028.USD","BBAI","BK4082","EBS","BK4587","LU1061106388.HKD","LU2362541273.HKD","LU0345769631.USD","LU2506951958.HKD","BK4539","BK4588","LU0950375773.USD","ARQT","BK4583","LU0882574055.USD","LU1804176565.USD","LU2087625088.SGD","IE00BJT1NW94.SGD","LU2491049909.HKD","BK4581","LU2362540622.SGD"],"gpt_icon":1},{"id":"2495510807","title":"Artiva Biotherapeutics initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2495510807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495510807?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:05","pubTimestamp":1735556704,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of Artiva Biotherapeutics (ARTV) with a Buy rating and $20 price target Artiva is a clinical stage biotechnology...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2495517637","title":"Artiva Biotherapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2495517637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495517637?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:02","pubTimestamp":1735556559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nAZN2YEU1N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2489553412","title":"AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2489553412","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489553412?lang=en_us&edition=fundamental","pubTime":"2024-12-06 23:36","pubTimestamp":1733499360,"startTime":"0","endTime":"0","summary":"Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy  designation to its pipeline candidate, acimtamig .The regulatory body granted the RMAT designation to acimtamig in combination with Artiva Biotherapeutic’s ARTV AlloNK  for the treatment of relapsed or refractory Hodgkin Lymphoma .Despite the FDA’s RMAT designation, shares of Affimed were down 6.5% on Dec. 5 following the announcement of the news. The stock, however, rebounded in after-hour trading and was up 5.6%.The RMAT designation provides the candidate with increased opportunities to meet FDA officials, as well as arrange early meetings to discuss potential surrogate or intermediate endpoints. It opens up early interactions between the FDA and sponsors to facilitate accelerated approval and potential priority review of a product’s biologics license application.Year to date, shares of Affimed have plunged 62.9% compared with the industry’s decline of 8%.In the past 60 days, estimates fo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/afmd-stock-down-despite-fdas-153600588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRO","CSTL","ARTV","BK4196","AFMD","BK4139"],"gpt_icon":0},{"id":"2483180808","title":"Artiva Biotherapeutics Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483180808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483180808?lang=en_us&edition=fundamental","pubTime":"2024-11-14 12:44","pubTimestamp":1731559480,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. ( ($ARTV) ) has released its Q3 earnings. Here is a breakdown of the information Artiva Biotherapeutics, Inc. presente...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2483514008","title":"Artiva Biotherapeutics Price Target Maintained With a $23.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2483514008","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483514008?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:28","pubTimestamp":1731497280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 06:28 ET (11:28 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2483778200","title":"Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2483778200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483778200?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:57","pubTimestamp":1731495460,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. (ARTV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-strong-buy-rating-supported-by-robust-autoimmune-pipeline-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-strong-buy-rating-supported-by-robust-autoimmune-pipeline-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"gpt_icon":0},{"id":"2483018722","title":"Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2483018722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483018722?lang=en_us&edition=fundamental","pubTime":"2024-11-13 10:05","pubTimestamp":1731463526,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Buy rating on Artiva Biotherapeutics, Inc. (ARTV – Research Report) yesterday. The company’s shares c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-artv-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-artv-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","BK4566","BK4585","BK4127","ARTV","BK4139","TD","BK4207"],"gpt_icon":0},{"id":"2483606658","title":"Artiva Biotherapeutics reports Q3 EPS (92c), consensus (91c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483606658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483606658?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:10","pubTimestamp":1731449409,"startTime":"0","endTime":"0","summary":"“As AlloNK advances in the clinic, we were pleased to expand our Board of Directors with the appointment of Dr. Alison Moore, an experienced execut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-reports-q3-eps-92c-consensus-91c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-reports-q3-eps-92c-consensus-91c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"gpt_icon":0},{"id":"2483063816","title":"Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483063816","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483063816?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:51","pubTimestamp":1731448272,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.91) by 1.1 percent. This is a 156.79 percent decrease over earnings of $1.62 per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41921746/artiva-biotherapeutics-q3-eps-0-92-misses-0-91-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2483050560","title":"Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050560","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483050560?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK in autoimmune diseases Initial data for AlloNK in autoimmune indica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979665/0/en/Artiva-Biotherapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTO","BK4077","BK4139","BK4160","ARTV","SLE"],"gpt_icon":0},{"id":"2482526765","title":"Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2482526765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482526765?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:05","pubTimestamp":1731359100,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  11, 2024  (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978559/0/en/Artiva-Biotherapeutics-to-Participate-in-the-Jefferies-London-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4139","HCSG","ARTV"],"gpt_icon":0},{"id":"2477394643","title":"BRIEF-Artiva Biotherapeutics Appoints Alison Moore To Its Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2477394643","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477394643?lang=en_us&edition=fundamental","pubTime":"2024-10-23 05:50","pubTimestamp":1729633835,"startTime":"0","endTime":"0","summary":"Oct 22 (Reuters) - Artiva Biotherapeutics   :   * ARTIVA BIOTHERAPEUTICS APPOINTS ALISON MOORE, PH.D., TO ITS BOARD OF DIRECTORSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ALLO","BK4139","ARTV"],"gpt_icon":0},{"id":"2477360977","title":"Artiva Biotherapeutics Appoints Alison Moore, Ph.d., to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2477360977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477360977?lang=en_us&edition=fundamental","pubTime":"2024-10-23 04:05","pubTimestamp":1729627502,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUA6LNW4K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLO","CDXS","BK4505","BK4121","ARTV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivabio.com","stockEarnings":[{"period":"1week","weight":0.0179},{"period":"1month","weight":-0.1283},{"period":"3month","weight":-0.2749},{"period":"6month","weight":-0.145},{"period":"ytd","weight":0.0179}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Artiva Biotherapeutics, Inc.","nameEN":"Artiva Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artiva Biotherapeutics, Inc.(ARTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Artiva Biotherapeutics, Inc.(ARTV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Artiva Biotherapeutics, Inc.,ARTV,Artiva Biotherapeutics, Inc.股票,Artiva Biotherapeutics, Inc.股票老虎,Artiva Biotherapeutics, Inc.股票老虎国际,Artiva Biotherapeutics, Inc.行情,Artiva Biotherapeutics, Inc.股票行情,Artiva Biotherapeutics, Inc.股价,Artiva Biotherapeutics, Inc.股市,Artiva Biotherapeutics, Inc.股票价格,Artiva Biotherapeutics, Inc.股票交易,Artiva Biotherapeutics, Inc.股票购买,Artiva Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artiva Biotherapeutics, Inc.(ARTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Artiva Biotherapeutics, Inc.(ARTV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction